Diversified Healthcare Tr Stock Price, News & Analysis

Diversified Healthcare Trust (Nasdaq: DHC) announced a regular quarterly cash distribution of $0.01 per common share, amounting to $0.04 annually. This distribution will be paid to shareholders of record by the close of business on January 23, 2023, with payments expected on or about February 16, 2023. As of September 30, 2022, DHC's portfolio was valued at approximately $7.0 billion and included 379 properties across 36 states and Washington, D.C., highlighting its diversified presence in the healthcare real estate sector.

Diversified Healthcare Trust (NASDAQ: DHC) reported a net loss of $81.5 million or $0.34 per share for Q3 2022, reflecting ongoing challenges in its senior housing operating portfolio (SHOP). Despite a strong leasing performance in its office segment, with a 4.7% increase in same property cash basis NOI year-over-year, the SHOP segment faced significant operating expenses due to Hurricane Ian and inflationary pressures. As of September 30, 2022, DHC maintained liquidity with $800.8 million in cash and no significant debt maturities until 2024.

Diversified Healthcare Trust (Nasdaq: DHC) announced a quarterly cash distribution of $0.01 per common share, equivalent to $0.04 annually. This dividend will be payable to shareholders on record as of October 24, 2022, with distribution occurring on or about November 17, 2022. DHC holds a diverse portfolio of healthcare properties valued at approximately $6.9 billion, comprising 378 properties across 36 states and Washington, D.C., totaling about 9 million square feet. The Trust is managed by The RMR Group (Nasdaq: RMR).

Diversified Healthcare Trust (Nasdaq: DHC) will release its third quarter 2022 financial results after market close on November 2, 2022. A conference call led by President Jennifer Francis and CFO Richard Siedel will be held on November 3, 2022, at 10:00 a.m. ET. Participants can join via a dedicated telephone line or listen online. DHC, a real estate investment trust with a $6.9 billion portfolio, operates 378 properties across 36 states, focusing on high-quality healthcare assets. The company is managed by The RMR Group (Nasdaq: RMR), overseeing assets worth over $37 billion.

Diversified Healthcare Trust (Nasdaq: DHC) reported a net loss of $109.4 million or $0.46 per share for Q2 2022, despite a $6.3 million increase in NOI driven by improved senior living occupancy. The company achieved a 23.3% rise in adjusted EBITDAre and saw a 9.1% increase in rental rates on a segment of their Office Portfolio. However, normalized FFO was negative at ($10.4 million) or ($0.04) per share. The balance sheet strengthened with a $108 million equity sale and a $500 million redemption of senior notes, reducing interest expenses by approximately $49 million.

Diversified Healthcare Trust (Nasdaq: DHC) announced the acquisition of a property at 47071 Bayside Parkway, Fremont, CA, for $82 million. This acquisition reflects a GAAP cap rate of 6.5% and adds to DHC’s growing life science portfolio in the San Francisco Bay area. The property, fully leased to Alamar Bioscience through January 2034, spans 89,000 square feet. DHC now owns four life science assets in this market, totaling approximately 327,000 square feet. The company holds assets worth about $6.8 billion across 36 states and D.C.

Diversified Healthcare Trust (Nasdaq: DHC) has announced a quarterly dividend of $0.01 per common share, totaling $0.04 annually. The dividend will be paid to shareholders of record on July 25, 2022, with distribution expected around August 18, 2022. DHC, which operates a diverse portfolio of healthcare properties worth approximately $6.8 billion, aims for broad diversification across healthcare services types.

Diversified Healthcare Trust (Nasdaq: DHC) will release its second quarter 2022 financial results on August 3, 2022, after Nasdaq's market close. A conference call with CEO Jennifer Francis and CFO Richard Siedel is scheduled for August 4, 2022, at 10:00 a.m. ET. Investors can access the call by dialing (877) 329-4297 or (412) 317-5435 for international participants. A replay will be available until August 11, 2022. DHC owns approximately $6.8 billion in healthcare properties across 36 states and Washington, D.C., including over 100 life science and medical office properties totaling nine million square feet.

Diversified Healthcare Trust (Nasdaq: DHC) has announced the sale of a 10% equity interest in its life science complex located in Boston for approximately $108 million. This transaction values the property at $1.7 billion after accounting for $620 million of existing debt. DHC intends to utilize the proceeds for capital expenditures, debt reduction, and general business purposes. The complex is nearly fully leased to Vertex Pharmaceuticals and reflects DHC's significant healthcare property portfolio valued at $6.8 billion.